Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once …
Mainstream Media Starts the Morning with MAPS November 24, 2021 Features about MAPS aired on several morning news shows this month! On November 14, CBS News aired an investigative report about treating …
In the Netherlands there are almost 150,000 people who suffer from post-traumatic stress disorder (PTSD). They have experienced something so intense that it left them traumatized. As a result, they suffer …
Summary: In a new episode of the Shrink Speak Podcast, Dr. Jeffrey Lieberman speaks with MAPS Founder Rick Doblin, Ph.D., and Dr. Steven Levine to explore recent progress in psychedelic research, therapeutic …
CBS News airs an investigative report about treating PTSD with MDMA-assisted therapy on a new episode of CBS Sunday Morning. In a series of interviews with David Martin of CBS, former Marine Scott Ostrom …
The New York Times publishes an in-depth report on Veterans advancing the field of psychedelic medicine, highlighting personal experiences, public advocacy, drug policy reform efforts, and new initiatives …
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
MAPS is on The TODAY Show! This morning, NBC educated millions of people about psychedelic science by airing an interview with MAPS Founder Rick Doblin, Ph.D., and MDMA-assisted therapy study participants …
The Multidisciplinary Association for Psychedelic Studies (MAPS) is honored to announce the election of Carl L. Hart, Ph.D., to MAPS’ Board of Directors, effective as of October 22, 2021. Dr. Carl Hart, …
Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted …
Psychedelic Science Expands Through Collaboration New publication in Nature Medicine, expansion of investigator-initiated trials, and new opportunities to contribute October 29, 2021 Dear friends and supporters, …
